Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial.
J Thromb Haemost. 2020 Feb;18(2):411-421. doi: 10.1111/jth.14662. Epub 2019 Nov 28.
J Thromb Haemost. 2020.
PMID: 31630479
Free article.
Clinical Trial.